Ho AL, Dedecjus M, Wirth LJ, Tuttle RM, Inabnet WB, 3rd, Tennvall J, et al. Selumetinib Plus Adjuvant Radioactive Iodine in Patients With High-Risk Differentiated Thyroid Cancer: A Phase III, Randomized, Placebo-Controlled Trial (ASTRA). J Clin Oncol. 2022;40(17):1870-8.

Article  CAS  PubMed  Google Scholar 

Baloch ZW, Asa SL, Barletta JA, Ghossein RA, Juhlin CC, Jung CK, et al. Overview of the 2022 WHO Classification of Thyroid Neoplasms. Endocr Pathol. 2022;33(1):27-63.

Article  PubMed  Google Scholar 

Wong KS, Dong F, Telatar M, Lorch JH, Alexander EK, Marqusee E, et al. Papillary Thyroid Carcinoma with High-Grade Features Versus Poorly Differentiated Thyroid Carcinoma: An Analysis of Clinicopathologic and Molecular Features and Outcome. Thyroid. 2021;31(6):933-40.

Article  CAS  PubMed  Google Scholar 

Wong KS, Lorch JH, Alexander EK, Marqusee E, Cho NL, Nehs MA, et al. Histopathologic Features and Clinical Outcome of Anaplastic Thyroid Carcinoma with a Minor Anaplastic Component. Endocr Pathol. 2020;31(3):283-90.

Article  PubMed  Google Scholar 

Wong KS, Lorch JH, Alexander EK, Marqusee E, Cho NL, Nehs MA, et al. Prognostic Significance of Extent of Invasion in Poorly Differentiated Thyroid Carcinoma. Thyroid. 2019;29(9):1255-61.

Article  PubMed  Google Scholar 

Akaishi J, Kondo T, Sugino K, Ogimi Y, Masaki C, Hames KY, et al. Prognostic Impact of the Turin Criteria in Poorly Differentiated Thyroid Carcinoma. World J Surg. 2019;43(9):2235-44.

Article  PubMed  Google Scholar 

Landa I, Ibrahimpasic T, Boucai L, Sinha R, Knauf JA, Shah RH, et al. Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. J Clin Invest. 2016;126(3):1052-66.

Article  PubMed  PubMed Central  Google Scholar 

Kakudo K, Wakasa T, Ohta Y, Yane K, Ito Y, Yamashita H. Prognostic classification of thyroid follicular cell tumors using Ki-67 labeling index: risk stratification of thyroid follicular cell carcinomas. Endocr J. 2015;62(1):1-12.

Article  PubMed  Google Scholar 

Bai S, Baloch ZW, Samulski TD, Montone KT, LiVolsi VA. Poorly differentiated oncocytic (hürthle cell) follicular carcinoma: an institutional experience. Endocr Pathol. 2015;26(2):164-9.

Article  CAS  PubMed  Google Scholar 

Gnemmi V, Renaud F, Do Cao C, Salleron J, Lion G, Wemeau JL, et al. Poorly differentiated thyroid carcinomas: application of the Turin proposal provides prognostic results similar to those from the assessment of high-grade features. Histopathology. 2014;64(2):263-73.

Article  PubMed  Google Scholar 

Bongiovanni M, Mazzucchelli L, Giovanella L, Frattini M, Pusztaszeri M. Well-differentiated follicular patterned tumors of the thyroid with high-grade features can metastasize in the absence of capsular or vascular invasion: report of a case. Int J Surg Pathol. 2014;22(8):749-56.

Article  PubMed  Google Scholar 

Dettmer M, Schmitt A, Steinert H, Moch H, Komminoth P, Perren A. Poorly differentiated oncocytic thyroid carcinoma--diagnostic implications and outcome. Histopathology. 2012;60(7):1045-51.

Article  PubMed  Google Scholar 

Volante M, Collini P, Nikiforov YE, Sakamoto A, Kakudo K, Katoh R, et al. Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol. 2007;31(8):1256-64.

Article  PubMed  Google Scholar 

Hiltzik D, Carlson DL, Tuttle RM, Chuai S, Ishill N, Shaha A, et al. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients. Cancer. 2006;106(6):1286-95.

Article  PubMed  Google Scholar 

Shaha A. Treatment of thyroid cancer based on risk groups. J Surg Oncol. 2006;94(8):683-91.

Article  PubMed  Google Scholar 

Volante M, Landolfi S, Chiusa L, Palestini N, Motta M, Codegone A, et al. Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients. Cancer. 2004;100(5):950-7.

Article  PubMed  Google Scholar 

Sobrinho-Simões M, Sambade C, Fonseca E, Soares P. Poorly differentiated carcinomas of the thyroid gland: a review of the clinicopathologic features of a series of 28 cases of a heterogeneous, clinically aggressive group of thyroid tumors. Int J Surg Pathol. 2002;10(2):123-31.

Article  PubMed  Google Scholar 

Tallini G, Garcia-Rostan G, Herrero A, Zelterman D, Viale G, Bosari S, et al. Downregulation of p27KIP1 and Ki67/Mib1 labeling index support the classification of thyroid carcinoma into prognostically relevant categories. Am J Surg Pathol. 1999;23(6):678-85.

Article  CAS  PubMed  Google Scholar 

Loree TR. Therapeutic implications of prognostic factors in differentiated carcinoma of the thyroid gland. Semin Surg Oncol. 1995;11(3):246-55.

Article  CAS  PubMed  Google Scholar 

Shaha AR, Loree TR, Shah JP. Intermediate-risk group for differentiated carcinoma of thyroid. Surgery. 1994;116(6):1036–40; discussion 40–1.

Carcangiu ML, Zampi G, Rosai J. Poorly differentiated ("insular") thyroid carcinoma. A reinterpretation of Langhans' "wuchernde Struma". Am J Surg Pathol. 1984;8(9):655–68.

Xu B, Ibrahimpasic T, Wang L, Sabra MM, Migliacci JC, Tuttle RM, et al. Clinicopathologic Features of Fatal Non-Anaplastic Follicular Cell-Derived Thyroid Carcinomas. Thyroid. 2016;26(11):1588-97.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu B, David J, Dogan S, Landa I, Katabi N, Saliba M, et al. Primary high-grade non-anaplastic thyroid carcinoma: a retrospective study of 364 cases. Histopathology. 2022;80(2):322-37.

Article  PubMed  Google Scholar 

Xu B, Lubin DJ, Dogan S, Ghossein RA, Viswanathan K. Significance of oncocytic features in poorly differentiated thyroid carcinoma - a bi-institutional experience. Virchows Arch. 2023;482(3):479–91.

Amin MG, DM; Meyer Vega, LR; Edge, SB; Greene, FL; Byrd, DR; Brookland, RK; Washington, MK; Compton, CC. American Joint Committee on Cancer Staging Manual. 8th ed. Amin M, editor. New York: Springer; 2018.

Rivera M, Ricarte-Filho J, Patel S, Tuttle M, Shaha A, Shah JP, et al. Encapsulated thyroid tumors of follicular cell origin with high grade features (high mitotic rate/tumor necrosis): a clinicopathologic and molecular study. Hum Pathol. 2010;41(2):172-80.

Article  CAS  PubMed  Google Scholar 

Xu B, Ghossein RA. Advances in Thyroid Pathology: High Grade Follicular Cell-derived Thyroid Carcinoma and Anaplastic Thyroid Carcinoma. Adv Anat Pathol. 2023;30(1):3-10.

Article  CAS  PubMed  Google Scholar 

Juhlin CC, Mete O, Baloch ZW. The 2022 WHO classification of thyroid tumors: novel concepts in nomenclature and grading. Endocr Relat Cancer. 2023;30(2):e220293.

Ghossein R. Problems and controversies in the histopathology of thyroid carcinomas of follicular cell origin. Arch Pathol Lab Med. 2009;133(5):683-91.

Article  PubMed  Google Scholar 

Volante M, Lam AK, Papotti M, Tallini G. Molecular Pathology of Poorly Differentiated and Anaplastic Thyroid Cancer: What Do Pathologists Need to Know? Endocr Pathol. 2021;32(1):63-76.

Article  CAS  PubMed  PubMed Central  Google Scholar